Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling
Konstantin Okonechnikov(German Cancer Research Center), Andrey Korshunov(German Cancer Research Center), Tuyu Zheng(St. Jude Children's Research Hospital), Daniel Schrimpf(German Cancer Research Center), David R. Ghasemi(German Cancer Research Center), Till Milde(German Cancer Research Center), Stefan M. Pfister(Heidelberg University), Kristian W. Pajtler(German Cancer Research Center), Andreas von Deimling(German Cancer Research Center), Felix Sahm(German Cancer Research Center), Marcel Kool(German Cancer Research Center), Martin Mynarek(Universität Hamburg), Jan Köster(Amsterdam UMC Location University of Amsterdam), David Jones(German Cancer Research Center), Philipp Sievers(German Cancer Research Center), Svenja Tonn(Universität Hamburg)
Cited by 4
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
The whole-genome landscape of medulloblastoma subtypes
|Nature|2017|1.2k